In ABC-DLBCL tumor cells, prolonged B cell receptor (BCR) signaling leads to high levels of NF-κB pathway activity, whereas in GCB-DLBCL tumor cells, BCR signaling contributes to high levels of PI3K signaling activity (4, 5). The gene discussed is PIK3CD; the disease is diffuse large B-cell lymphoma.